Unknown

Dataset Information

0

Safety of a Restrictive versus Liberal Approach to Red Blood Cell Transfusion on the Outcome of AKI in Patients Undergoing Cardiac Surgery: A Randomized Clinical Trial.


ABSTRACT: BACKGROUND:Safely reducing red blood cell transfusions can prevent transfusion-related adverse effects, conserve the blood supply, and reduce health care costs. Both anemia and red blood cell transfusion are independently associated with AKI, but observational data are insufficient to determine whether a restrictive approach to transfusion can be used without increasing AKI risk. METHODS:In a prespecified kidney substudy of a randomized noninferiority trial, we compared a restrictive threshold for red blood cell transfusion (transfuse if hemoglobin<7.5 g/dl, intraoperatively and postoperatively) with a liberal threshold (transfuse if hemoglobin<9.5 g/dl in the operating room or intensive care unit, or if hemoglobin<8.5 g/dl on the nonintensive care ward). We studied 4531 patients undergoing cardiac surgery with cardiopulmonary bypass who had a moderate-to-high risk of perioperative death. The substudy's primary outcome was AKI, defined as a postoperative increase in serum creatinine of ?0.3 mg/dl within 48 hours of surgery, or ?50% within 7 days of surgery. RESULTS:Patients in the restrictive-threshold group received significantly fewer transfusions than patients in the liberal-threshold group (1.8 versus 2.9 on average, or 38% fewer transfusions in the restricted-threshold group compared with the liberal-threshold group; P<0.001). AKI occurred in 27.7% of patients in the restrictive-threshold group (624 of 2251) and in 27.9% of patients in the liberal-threshold group (636 of 2280). Similarly, among patients with preoperative CKD, AKI occurred in 33.6% of patients in the restrictive-threshold group (258 of 767) and in 32.5% of patients in the liberal-threshold group (252 of 775). CONCLUSIONS:Among patients undergoing cardiac surgery, a restrictive transfusion approach resulted in fewer red blood cell transfusions without increasing the risk of AKI.

SUBMITTER: Garg AX 

PROVIDER: S-EPMC6622429 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6430679 | BioStudies
2015-01-01 | S-EPMC4443456 | BioStudies
2019-01-01 | S-EPMC6419414 | BioStudies
1000-01-01 | S-EPMC3222066 | BioStudies
2017-01-01 | S-EPMC5848498 | BioStudies
2014-01-01 | S-EPMC4203913 | BioStudies
2013-01-01 | S-EPMC3743942 | BioStudies
2019-01-01 | S-EPMC6659290 | BioStudies
2021-01-01 | S-EPMC7852166 | BioStudies
2020-01-01 | S-EPMC7313211 | BioStudies